Sunny Reddy

Sunny Reddy is currently an Analyst at Aisling Capital, where he evaluates and executes venture capital investments across the healthcare, biotechnology, and broader life sciences sectors. Prior to joining the firm in 2019, he worked as an investment banking Associate and Analyst at SVB Leerink, advising on complex financial transactions. He completed his graduate education by earning a Master of Business Administration degree from Columbia Business School. In his current investment role, Reddy provides strategic board oversight and rigorous financial analysis, serving as an active Board Observer for several portfolio companies, including Mindful Health Solutions, Garuda Therapeutics, and Wugen. Additionally, he previously contributed to corporate governance by holding a board observer position at Forge Biologics. His professional background remains focused on advancing clinical and commercial-stage healthcare enterprises through targeted venture capital funding and institutional advisory services.